Aug 17 |
3 Fantastic Growth Stocks to Buy in August
|
Aug 17 |
Eli Lilly's Top GLP-1 Drugs Now Account for Nearly 40% of Its Revenue, and That's Likely to Go Higher in Future Quarters
|
Aug 16 |
Lilly announces retirement of Marschall S. Runge from its Board of Directors
|
Aug 16 |
Why Lilly (LLY) Might be Well Poised for a Surge
|
Aug 16 |
Top Midday Stories: B. Riley Co-Founder Offers to Buy Rest of Company; Ford Recalls 85,000 Explorers
|
Aug 16 |
3 Companies Reporting Remarkable Results: WMT, LLY, CAH
|
Aug 16 |
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
|
Aug 16 |
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
|
Aug 15 |
What Makes Eli Lilly (LLY) a Strong Momentum Stock: Buy Now?
|
Aug 15 |
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
|